Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Kesselheim, Aaron
Item TypeName
Academic Article User fees and beyond--the FDA Safety and Innovation Act of 2012.
Academic Article Market-based licensing for HPV vaccines in developing countries.
Academic Article Balancing innovation, access, and profits--market exclusivity for biologics.
Academic Article The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients.
Academic Article State generic substitution laws can lower drug outlays under Medicaid.
Concept Fees, Pharmaceutical
Concept Fees and Charges
Concept Prescription Fees
Academic Article Prescription-drug coupons--no such thing as a free lunch.
Academic Article Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Academic Article Progress and Hurdles for Follow-on Biologics.
Academic Article Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.
Academic Article Public referendum on drug prices in the US: will it bring relief?
Academic Article The Price of Crossing the Border for Medications.
Academic Article Legal Challenges to State Drug Pricing Laws.
Academic Article Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
Academic Article An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
Academic Article Changes in Drug Pricing After Drug Shortages in the United States.
Search Criteria
  • Fees and Charges
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.